Medicare underpayment for Diabetes Prevention Program: implications for DPP suppliers.
CONCLUSIONS: In a large urban health system serving a diverse population, the costs of delivering DPP far outweighed Medicare reimbursement amounts. Analyzing and documenting the costs associated with delivering the evidence-based DPP may inform prospective suppliers and payers and aid in advocacy for adequate reimbursement.
PMID: 30325189 [PubMed - in process]
Source: The American Journal of Managed Care - Category: Health Management Authors: Parsons AS, Raman V, Starr B, Zezza M, Rehm CD Tags: Am J Manag Care Source Type: research
More News: Diabetes | Endocrinology | Health Management | Managed Care | Medicare | Study | Weight Loss